{"nct_id":"NCT02674061","title":"Efficacy and Safety Study of Pembrolizumab (MK-3475) in Participants With Advanced Recurrent Ovarian Cancer (MK-3475-100/KEYNOTE-100)","status":"COMPLETED","status_verified_date":"2022-02","start_date":"2016-02-25","start_date_type":"ACTUAL","primary_completion_date":"2019-09-18","primary_completion_date_type":"ACTUAL","completion_date":"2021-03-18","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["MRK"]}